as on January 22, 2026 at 9:22 am IST
Day's Low
0.25%
Downside
52 Week's Low
52 Week's High
4.45%
Downside
67.70%
Upside
as on January 22, 2026 at 9:22 am IST
Market Cap
₹267.37 Cr
Return on Equity (ROE)
6.69
PE Ratio (TTM)
6.19
Return on capital employed (ROCE)
7.25
Industry PE ratio
57.69
Beta (LTM)
1.14
P/B Ratio
0.43
Dividend Yield
1.37
PEG Ratio
7.55
Quarterly Earnings Growth YOY
147.75
EPS (TTM)
20.31
Sector
FMCG
Book Value
339.08
Technical Analysis
Bearish
View Technical Analysis
as on January 22, 2026 at 9:22 am IST
Nath Bio-Genes in the last 5 years
Lowest (-3.78x)
January 3, 2023
Today (6.19x)
January 21, 2026
Industry (57.69x)
January 21, 2026
Highest (11.85x)
August 4, 2023
Today’s Price to Earnings Ratio: 6.19x
Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 267.37 | -10.01% | 0.58 | 38 | 364 | |
| NA | 964.06 | 7.31% | 0.59 | 48 | 556 | |
| NA | 2,056.47 | -1.26% | 0.00 | NA | NA | |
| NA | 63.41 | 39.22% | 0.76 | 5 | 834 | |
| NA | 70.20 | 5.73% | 0.00 | 4 | 147 |
Get share price movements and forecasts by analysts on Nath Bio-Genes.
Source: S&P Global Market Intelligence
Search interest for Nath Bio-Genes (India) Ltd Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Nath Bio-Genes.
Nath Bio-Genes (India) Ltd’s net profit jumped 147.75% since last year same period to ₹2.75Cr in the Q2 2025-2026. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -92.62% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.88%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 51.74% to 53.32% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 45.60% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Avanti Feeds Ltd has given 21.5% return, outperforming this stock by 43.1%
Against Peers
![]()
In the last 3 years, Avanti Feeds Ltd has given 101.7% return, outperforming this stock by 115.4%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.41% to 0.32% in Sep 2025 quarter
MF Holding Down
![]()
Mutual Funds have decreased holdings from 2.25% to 0.76% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 287.53 Cr → 47.85 Cr (in ₹), with an average decrease of 83.4% per quarter
Price Dip
![]()
In the last 7 days, NATHBIOGEN stock has moved down by -6.5%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 37.28 Cr → 2.75 Cr (in ₹), with an average decrease of 92.6% per quarter
| Organisation | Nath Bio-Genes (India) Ltd |
| Industry | FMCG |
| E-voting on shares | Click here to vote |
Nath Bio-Genes share price today stands at ₹142.33 as on . Nath Bio-Genes share today touched a day high of ₹142.33 and a low of ₹141.98.
Nath Bio-Genes touched a 52 week high of ₹238.69 and a 52 week low of ₹136. Nath Bio-Genes share price today i.e. is trending at ₹142.33, which is -40.37% down from its 52 week high and 4.65% up from its 52 week low.
Nath Bio-Genes market capitalisation is ₹267.37 Cr as on .
To buy Nath Bio-Genes shares, you need to follow these steps:
Nath Bio-Genes trading volume is 647.00 as on . This means that 647.00 shares of Nath Bio-Genes were bought and sold on the stock market during today's trading session.